SCINOVA Engage

Scientific Consultancy

Translating Research
Into Strategic Decisions.

SCINOVA partners with healthcare, life sciences, and rare disease organisations to convert complex evidence into clear, defensible direction.

Explore Services → Our Approach

What We Do

A consultancy built for evidence-led decisions.

Four interlocking practices that move scientific work from question to outcome — designed for healthcare, life sciences, and rare disease portfolios.

  • 01

    Research Strategy

    Direction-setting for evidence generation: scoping questions, designing programmes, and aligning research to commercial and clinical objectives.

    Discuss this practice →
  • 02

    Data & Analytics

    Quantitative and mixed-methods analytics that turn datasets into structured insight — from real-world evidence to outcomes modelling.

    Discuss this practice →
  • 03

    Evidence Synthesis

    Systematic reviews, meta-analyses, and rapid landscape reports translating fragmented literature into defensible positions.

    Discuss this practice →
  • 04

    Translational Insight

    Bridging science and strategy: turning study findings into briefings, advisory papers, and decisions stakeholders can act on.

    Discuss this practice →

Our Approach

A four-stage methodology pipeline.

Each engagement progresses through structured stages — designed for transparency, reproducibility, and decision-readiness.

  1. 01

    Discover

    Scope the question. Map the evidence landscape, stakeholders, and decision context.

  2. 02

    Analyze

    Interrogate the data. Apply rigorous methods — quantitative, qualitative, systematic.

  3. 03

    Integrate

    Synthesize findings into structured insight. Reconcile signal across sources.

  4. 04

    Advance

    Translate insight into action — briefings, strategy, and recommendations that hold up to scrutiny.

Insights

Thought leadership, abstracted from practice.

Selected whitepapers, briefs, and field notes — written like research, not like marketing.

  • Whitepaper Forthcoming

    Translating rare disease evidence into payer-ready submissions.

    A structured framework for converting fragmented clinical evidence into HTA-grade dossiers.

    Request preview →
  • Brief Forthcoming

    Real-world evidence governance in emerging markets.

    Practical guardrails for designing RWE programmes where registry infrastructure is still maturing.

    Request preview →
  • Note Forthcoming

    On the boundary between research strategy and commercial strategy.

    Why evidence work that does not anticipate decision context rarely changes outcomes.

    Request preview →

Case Studies

Selected engagements.

Each engagement is structured academically — problem, method, insight, outcome. Names and identifying details are withheld; structure is preserved.

01

Rare Disease

Problem
A specialty pharma client needed to position a rare disease therapy across fragmented evidence and divergent payer environments.
Method
Mixed-methods evidence synthesis combining systematic literature review with stakeholder interviews across three regions.
Insight
Identified a consistent unmet-need signature that anchored the payer narrative and harmonised regional messaging.
Outcome
Submission pack accepted in first review cycle; informed market access strategy across two additional markets.
02

Healthcare Systems

Problem
A regional health authority sought to design an outcomes-tracking programme without disrupting clinical workflow.
Method
Translational analytics combining workflow mapping, data-readiness audit, and outcomes framework design.
Insight
Existing administrative datasets carried 70% of required signal once linked — net new collection was minimal.
Outcome
A staged programme delivered on a 6-month pilot, with measurable outcomes reporting from quarter one.

Engage

Begin a conversation with SCINOVA.

Tell us about the question you are trying to answer. We respond to every enquiry within two working days.

hello@scinovaresearch.com Review our approach